# Systematic Review: Medical Cannabis for Diabetic Peripheral Neuropathy > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/medical-cannabis-diabetic-neuropathy-review/ > **Published:** 2026-03-24T16:55:04-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:40:37-04:00 > **Clinical Summary:** Explore medical cannabis diabetic neuropathy evidence from randomized trials showing potential pain relief benefits and considerations for diabetic patients. --- CED Clinical Relevance  #100High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. 🔬 Evidence Watch  |  CED Clinic NeuropathyPainThcDiabetesRct Journal Cannabis and [cannabinoid research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) Study Type Randomized Trial Population Human participants Why This Matters Diabetic peripheral neuropathy affects up to 50% of diabetes patients and remains notoriously difficult to treat with conventional medications. This systematic review provides the first focused analysis of cannabis-based interventions specifically for this population, addressing a critical gap in evidence-based treatment options. Clinical Summary This systematic review analyzed four randomized controlled trials examining cannabis interventions in diabetic peripheral neuropathy patients. Three of four studies demonstrated statistically significant pain reduction compared to placebo, with vaporized or sublingual THC at 16-18 mg doses showing clinically meaningful benefits. Common adverse effects included dizziness and cognitive symptoms, typically mild-to-moderate in severity. The review was limited by the small number of available trials and heterogeneity in study designs and outcome measures. Dr. Caplan’s Take “While encouraging, four small trials don’t constitute robust evidence for routine clinical recommendation. I remain cautiously optimistic about THC’s potential for diabetic neuropathy, but we need larger, longer-term studies before this becomes standard practice.” Clinical Perspective 🧠 Clinicians should view these findings as preliminary but promising evidence for cannabis as adjuvant therapy in refractory diabetic neuropathy cases. Patients interested in this approach should be counseled about the limited evidence base, potential cognitive effects, and need for careful dose titration starting well below the 16-18 mg range identified in these studies. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Medical%20Cannabis%20for%20the%20Treatment%20of%20Peripheral%20Neuropathy%20due%20to%20Diabetes%3A%20A%20S...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41714301/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41714301/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Medical%20Cannabis%20for%20the%20Treatment%20of%20Peripheral%20Neuropathy%20due%20to%20Diabetes%3A%20A%20S...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41714301/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41714301/](https://pubmed.ncbi.nlm.nih.gov/41714301/) Table of Contents - [FAQ](#FAQ)[Is medical cannabis effective for diabetic neuropathy pain?](#Is_medical_cannabis_effective_for_diabetic_neuropathy_pain) - [What is the effective dose of THC for diabetic neuropathy?](#What_is_the_effective_dose_of_THC_for_diabetic_neuropathy) - [What are the common side effects of medical cannabis for neuropathy?](#What_are_the_common_side_effects_of_medical_cannabis_for_neuropathy) - [Can medical cannabis be used alongside other neuropathy treatments?](#Can_medical_cannabis_be_used_alongside_other_neuropathy_treatments) - [How should medical cannabis be administered for diabetic neuropathy?](#How_should_medical_cannabis_be_administered_for_diabetic_neuropathy) - [Related](#Related) ## FAQ #### Is medical cannabis effective for diabetic neuropathy pain? Yes, three of four randomized controlled trials showed statistically significant reductions in [neuropathic pain](https://cedclinic.com/cannabis-for-pain-relief/) with cannabinoid-based interventions compared to placebo. The evidence suggests [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) can be an effective adjuvant treatment for painful diabetic peripheral neuropathy. #### What is the effective dose of THC for diabetic neuropathy? Studies using vaporized or sublingual THC found that doses of approximately 16-18 mg were associated with clinically meaningful pain relief in participants. These doses were tested in controlled trials and demonstrated therapeutic benefit for [neuropathic pain](https://cedclinic.com/cannabis-for-pain-relief/). #### What are the common side effects of medical cannabis for neuropathy? The most common adverse effects include dizziness and cognitive symptoms, which were generally mild to moderate in severity. While [side effects](https://cedclinic.com/cannabis-intoxication-memory-disruption/) were common, they were typically manageable and discontinuation rates due to adverse effects varied across studies. #### Can medical cannabis be used alongside other neuropathy treatments? Yes, the research evaluated [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) as an adjuvant (add-on) treatment for diabetic peripheral neuropathy. This suggests it can be used in combination with existing therapies rather than as a replacement for standard care. #### How should medical cannabis be administered for diabetic neuropathy? The effective trials used vaporized or sublingual (under the tongue) administration methods for THC delivery. These routes of administration allowed for controlled dosing and demonstrated clinical effectiveness in the study participants. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Medical Cannabis for the Treatment of Peripheral Neuropathy due to Diabetes: A Systematic Review.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41714301/”, “about”: “cannabis [cannabinoid research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) randomized trial medical”, “isPartOf”: “Cannabis and cannabinoid research”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis-based interventions might help a little with neuropathic pain – Study Summary](https://cedclinic.com/cannabis-neuropathic-pain-relief-modest-benefits/) Summary of research on cannabis interventions for neuropathic pain, highlighting modest benefits and clinical considerations. [Read Study Summary](https://cedclinic.com/cannabis-neuropathic-pain-relief-modest-benefits/) [Cannabinoids for Nerve Pain: What the Best Clinical Evidence Says About Sleep and Pain Relief](https://cedclinic.com/cannabinoid-therapy-neuropathic-pain-sleep-relief/) Review of clinical evidence on cannabinoids for nerve pain, focusing on pain relief and sleep improvements. [Explore Clinical Evidence](https://cedclinic.com/cannabinoid-therapy-neuropathic-pain-sleep-relief/) [Some Cannabinoids May Ease Common Chronic Pain Conditions, Study Finds](https://cedclinic.com/some-cannabinoids-may-ease-common-chronic-pain-conditions-study-finds/) Study findings on cannabinoids easing various [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/) conditions, relevant to diabetic neuropathy management. [Discover Study Findings](https://cedclinic.com/some-cannabinoids-may-ease-common-chronic-pain-conditions-study-finds/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).